Eppendorf, BioDiscovery, CytRx, Affymetrix, BioForce Nanosciences, Sloning Biotechnology | GenomeWeb

Eppendorf Licenses BioDiscovery’s ImaGene for its Developing System

Eppendorf of Germany last week announced a licensing agreement with BioDiscovery of Marina Del Rey, Calif., and will integrate the company’s ImaGene software into a new line of microarray products that it plans to introduce within “the next few months,” the company said.

Financial details were not disclosed.

BioDiscovery will modify its ImaGene software to integrate Eppendorf statistical tools and other proprietary developments, the companies said in a joint announcement.


Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PLOS this week: a sequencing-based screen of Lyme disease-causing pathogen, the range of animals bitten by Anopheles darling mosquitoes in Peru, and more.

An NC State researcher is exploring the use of CRISPR-Cas3 as an anti-microbial, Gizmodo reports.

The Earth BioGenome Project plans to sequence all life on Earth, according to ScienceInsider.

For those who are concerned about Trump administration actions related to science, a new column in Scientific American has suggestions for ways to fight back.